Home » Topics » BioWorld Science, Patents

BioWorld Science, Patents
RSS

New GPR119 receptor agonists disclosed by Arena Pharmaceuticals

Oct. 29, 2012

Boehringer Ingelheim patents novel DP2 receptor antagonists

Oct. 29, 2012

Ares Trading discloses novel chemokine receptor ligands

Oct. 26, 2012

SJT Molecular Research divulges new agents for metabolic syndrome

Oct. 26, 2012

Swiss and German scientists synthesize new S1P receptor agonists

Oct. 26, 2012

Novel potassium channel blockers presented by Xention

Oct. 26, 2012

French group discloses novel agents for bone cancer

Oct. 26, 2012

Bayer Schering Pharma prepares new agents for cancer

Oct. 26, 2012

Duke University presents novel oligopeptides for inflammation and neurological conditions

Oct. 25, 2012

Researchers at Amgen patent novel protein kinase inhibitors

Oct. 25, 2012

Popular Stories

Today's news in brief
BioWorld
SCAN is core circuit affected in Parkinson’s disease
BioWorld Science
Parkinson’s disease (PD) is a neurodegenerative disorder that affects movement, and tremor is one of its signatures. But it is a much more wide-ranging disorder,...
IL-22 and TL1A, a robust couple for diagnosing hidradenitis suppurativa
BioWorld Science
Hidradenitis suppurativa (HS) is a chronic inflammatory skin disease with strong association with psoriasis and inflammatory bowel disease (IBD). While some...
TL1A is overexpressed in hidradenitis suppurativa
BioWorld Science
Despite the availability of advanced therapeutic options, about 40%-50% of patients with hidradenitis suppurativa do not achieve significant improvement in...
Inhibiting the NLRP3 inflammasome for cognitive impairment, stroke
BioWorld Science
Vascular cognitive impairment and dementia (VCID) and cerebral small vessel disease are among the leading causes of dementia, where inflammation is known to play...